William Blackstock

Papers

Total Citations

H-Index

About

William Blackstock is a leading clinical researcher in thoracic oncology, with a particular focus on optimizing treatment for early-stage non–small cell lung cancer. His major contributions center on patient-centered outcomes, especially quality of life, in patients who are not candidates for standard lobectomy. In his highly cited 2024 study, "Longitudinal quality of life after sublobar resection and stereotactic body radiation therapy for early‐stage non–small cell lung cancer," Blackstock provides critical, comparative data on how sublobar resection and SBRT affect patients' well-being over time. This work addresses a significant gap in the literature by moving beyond traditional survival metrics to capture the real-world experiences of a vulnerable patient population. With 9 citations already, this paper is rapidly shaping clinical decision-making and patient counseling. Blackstock’s research is distinguished by its rigorous longitudinal design and its direct relevance to personalized cancer care, helping clinicians and patients weigh the trade-offs between surgical and radiation-based approaches. His work stands as a vital resource for oncologists, surgeons, and researchers striving to improve both survival and quality of life in lung cancer care.